Literature DB >> 11226328

Urocortin II: a member of the corticotropin-releasing factor (CRF) neuropeptide family that is selectively bound by type 2 CRF receptors.

T M Reyes1, K Lewis, M H Perrin, K S Kunitake, J Vaughan, C A Arias, J B Hogenesch, J Gulyas, J Rivier, W W Vale, P E Sawchenko.   

Abstract

Here we describe the cloning and initial characterization of a previously unidentified CRF-related neuropeptide, urocortin II (Ucn II). Searches of the public human genome database identified a region with significant sequence homology to the CRF neuropeptide family. By using homologous primers deduced from the human sequence, a mouse cDNA was isolated from whole brain poly(A)(+) RNA that encodes a predicted 38-aa peptide, structurally related to the other known mammalian family members, CRF and Ucn. Ucn II binds selectively to the type 2 CRF receptor (CRF-R2), with no appreciable activity on CRF-R1. Transcripts encoding Ucn II are expressed in discrete regions of the rodent central nervous system, including stress-related cell groups in the hypothalamus (paraventricular and arcuate nuclei) and brainstem (locus coeruleus). Central administration of 1-10 microg of peptide elicits activational responses (Fos induction) preferentially within a core circuitry subserving autonomic and neuroendocrine regulation, but whose overall pattern does not broadly mimic the CRF-R2 distribution. Behaviorally, central Ucn II attenuates nighttime feeding, with a time course distinct from that seen in response to CRF. In contrast to CRF, however, central Ucn II failed to increase gross motor activity. These findings identify Ucn II as a new member of the CRF family of neuropeptides, which is expressed centrally and binds selectively to CRF-R2. Initial functional studies are consistent with Ucn II involvement in central autonomic and appetitive control, but not in generalized behavioral activation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11226328      PMCID: PMC30227          DOI: 10.1073/pnas.051626398

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  30 in total

1.  Hypothalamic integration: organization of the paraventricular and supraoptic nuclei.

Authors:  L W Swanson; P E Sawchenko
Journal:  Annu Rev Neurosci       Date:  1983       Impact factor: 12.449

Review 2.  Mismatches between neurotransmitter and receptor localizations in brain: observations and implications.

Authors:  M Herkenham
Journal:  Neuroscience       Date:  1987-10       Impact factor: 3.590

Review 3.  The role of limbic and hypothalamic corticotropin-releasing factor in behavioral responses to stress.

Authors:  F Menzaghi; S C Heinrichs; E M Pich; F Weiss; G F Koob
Journal:  Ann N Y Acad Sci       Date:  1993-10-29       Impact factor: 5.691

4.  Localization of novel corticotropin-releasing factor receptor (CRF2) mRNA expression to specific subcortical nuclei in rat brain: comparison with CRF1 receptor mRNA expression.

Authors:  D T Chalmers; T W Lovenberg; E B De Souza
Journal:  J Neurosci       Date:  1995-10       Impact factor: 6.167

5.  Conformationally restricted competitive antagonists of human/rat corticotropin-releasing factor.

Authors:  A Miranda; S C Koerber; J Gulyas; S L Lahrichi; A G Craig; A Corrigan; A Hagler; C Rivier; W Vale; J Rivier
Journal:  J Med Chem       Date:  1994-05-13       Impact factor: 7.446

6.  Expression of Fos-like protein in brain following sustained hypertension and hypotension in conscious rabbits.

Authors:  Y W Li; R A Dampney
Journal:  Neuroscience       Date:  1994-08       Impact factor: 3.590

Review 7.  The functional neuroanatomy of corticotropin-releasing factor.

Authors:  P E Sawchenko; T Imaki; E Potter; K Kovács; J Imaki; W Vale
Journal:  Ciba Found Symp       Date:  1993

8.  Distribution of corticotropin-releasing factor receptor mRNA expression in the rat brain and pituitary.

Authors:  E Potter; S Sutton; C Donaldson; R Chen; M Perrin; K Lewis; P E Sawchenko; W Vale
Journal:  Proc Natl Acad Sci U S A       Date:  1994-09-13       Impact factor: 11.205

9.  Organization of ovine corticotropin-releasing factor immunoreactive cells and fibers in the rat brain: an immunohistochemical study.

Authors:  L W Swanson; P E Sawchenko; J Rivier; W W Vale
Journal:  Neuroendocrinology       Date:  1983       Impact factor: 4.914

10.  Spatially and temporally differentiated patterns of c-fos expression in brainstem catecholaminergic cell groups induced by cardiovascular challenges in the rat.

Authors:  R K Chan; P E Sawchenko
Journal:  J Comp Neurol       Date:  1994-10-15       Impact factor: 3.215

View more
  209 in total

1.  Urocortin III-immunoreactive projections in rat brain: partial overlap with sites of type 2 corticotrophin-releasing factor receptor expression.

Authors:  Chien Li; Joan Vaughan; Paul E Sawchenko; Wylie W Vale
Journal:  J Neurosci       Date:  2002-02-01       Impact factor: 6.167

2.  NMR structure and peptide hormone binding site of the first extracellular domain of a type B1 G protein-coupled receptor.

Authors:  Christy R R Grace; Marilyn H Perrin; Michael R DiGruccio; Charleen L Miller; Jean E Rivier; Wylie W Vale; Roland Riek
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-23       Impact factor: 11.205

Review 3.  Minireview: CRF and Wylie Vale: a story of 41 amino acids and a Texan with grit.

Authors:  Tracy L Bale; Alon Chen
Journal:  Endocrinology       Date:  2012-04-04       Impact factor: 4.736

4.  Involvement of mTOR in Type 2 CRF Receptor Inhibition of Insulin Signaling in Muscle Cells.

Authors:  Hongxia Chao; Haochen Li; Rebecca Grande; Vitor Lira; Zhen Yan; Thurl E Harris; Chien Li
Journal:  Mol Endocrinol       Date:  2015-04-15

5.  Urocortin 2 Gene Transfer Reduces the Adverse Effects of a Western Diet on Cardiac Function in Mice.

Authors:  Young Chul Kim; Dimosthenis Giamouridis; N Chin Lai; Tracy Guo; Bing Xia; Zhenxing Fu; Mei Hua Gao; H Kirk Hammond
Journal:  Hum Gene Ther       Date:  2019-03-11       Impact factor: 5.695

6.  Cardiac CRFR1 Expression Is Elevated in Human Heart Failure and Modulated by Genetic Variation and Alternative Splicing.

Authors:  Anna P Pilbrow; Kathy A Lewis; Marilyn H Perrin; Wendy E Sweet; Christine S Moravec; W H Wilson Tang; Mark O Huising; Richard W Troughton; Vicky A Cameron
Journal:  Endocrinology       Date:  2016-10-18       Impact factor: 4.736

Review 7.  Corticotropin-releasing hormone-binding protein and stress: from invertebrates to humans.

Authors:  Kyle D Ketchesin; Gwen S Stinnett; Audrey F Seasholtz
Journal:  Stress       Date:  2017-05-18       Impact factor: 3.493

8.  One-time injection of AAV8 encoding urocortin 2 provides long-term resolution of insulin resistance.

Authors:  Mei Hua Gao; Dimosthenis Giamouridis; N Chin Lai; Evelyn Walenta; Vivian Almeida Paschoal; Young Chul Kim; Atsushi Miyanohara; Tracy Guo; Min Liao; Li Liu; Zhen Tan; Theodore P Ciaraldi; Simon Schenk; Aditi Bhargava; Da Young Oh; H Kirk Hammond
Journal:  JCI Insight       Date:  2016-09-22

9.  Residue 17 of sauvagine cross-links to the first transmembrane domain of corticotropin-releasing factor receptor 1 (CRFR1).

Authors:  Iman Assil-Kishawi; Tareq A Samra; Dale F Mierke; Abdul B Abou-Samra
Journal:  J Biol Chem       Date:  2008-10-27       Impact factor: 5.157

10.  Posttranslational processing of human and mouse urocortin 2: characterization and bioactivity of gene products.

Authors:  Joan M Vaughan; Cynthia J Donaldson; Wolfgang H Fischer; Marilyn H Perrin; Jean E Rivier; Paul E Sawchenko; Wylie W Vale
Journal:  Endocrinology       Date:  2013-03-14       Impact factor: 4.736

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.